"covid-19" prototype clinical trial, humira.
Ended Other Transaction Agreement Awarded Last action
- Contract number
- W911QY2190014
- Awardee
-
Allucent Government Services (Us) LLC UEI C7DJDL6EZT94
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $3,330,397
Award facts
- Contract value 10% obligated
-
- $3,330,397.33 Current, with exercised options
- $34,768,052.04 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
- Place of performance
- Houston, TX 77060, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | -$1,518,106 | |
| Funding Only Action | -$31,437,655 | |
| Other Administrative Action | $0 | |
| Original award | $36,286,158 |
About this award
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $34.8 million other transaction agreement to Pharm-Olam, LLC for a "COVID-19" prototype clinical trial involving the drug Humira. The prime contractor, Pharm-Olam LLC, will conduct work at its Houston, Texas facility from December 2020 through June 2022. No subcontractors or set-aside designations were identified. The award provides funding for Pharm-Olam to advance clinical testing of Humira, an anti-inflammatory drug, as a potential COVID-19 treatment. As the Joint PEO for Chemical and Biological Defense, the funding agency supports research and development programs to counter chemical and biological threats, consistent with the scope and purpose of this prototype clinical trial award.
Quick answers
Who was awarded contract W911QY2190014?
W911QY2190014 was awarded to Allucent Government Services (Us) LLC by ACC Aberdeen Proving Ground (Army Contracting Command) on December 31, 2020.
How much is contract W911QY2190014 worth?
The government has obligated $3,330,397 on W911QY2190014. Its potential value, with all options, is $34,768,052.
Which agency awarded contract W911QY2190014?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY2190014, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY2190014 competed?
The extent of competition for W911QY2190014 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award